What the work involves
This is a single-session research study, not a recurring contract. You complete a structured online survey — roughly 30 minutes — describing how you actually treat and manage adults with migraine: acute versus preventive strategy, how you sequence triptans, gepants, ditans, CGRP monoclonals and older preventives, how you handle medication-overuse headache, what makes you switch or escalate, and how comorbidities and payer constraints shape the plan. Expect a mix of multiple-choice items, ranking exercises, and free-text where your reasoning matters more than the label you pick. There are no voice recordings and no interview component.
The data feeds an AI research lab's work on healthcare tools, so the value sits in specificity. Answers that restate guideline text are less useful than answers that describe what you do when the guideline and the patient in front of you diverge. Free-text boxes are read.
What the platform screens for
- Verifiable specialty and licensure. MD or DO in neurology, currently licensed and seeing patients in the United States. Expect to supply NPI or licence details.
- Recent, hands-on migraine prescribing. You must have personally prescribed or renewed treatment for adult migraine patients within the last three months. Supervisory or consultative-only involvement typically does not qualify.
- Adult panel. Pediatric-only headache practice is generally out of scope for this study.
- Independent English completion. No assistants, no scribes filling it in on your behalf.
Logistics
Fully remote and asynchronous within the United States. You choose when to sit down with it; the only real constraint is the submission deadline you're given at invitation, which is usually short — days, not weeks. Compensation is a one-time $150 observed for this study, paid after the submission passes verification. Incomplete or straight-lined responses fail verification. Screening itself is AI-led and brief, mostly confirming credentials, patient population, and recent prescribing.